Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

NovaBay shareholders clear $10m stock deal

December 22, 2017 By Sarah Faulkner

NovaBay Pharmaceuticals (NYSE:NBY) said today that its shareholders have approved a deal to issue 2.4 million shares of common stock as part of a $10.3 million deal with Beijing-based Ch-gemstone Capital.

The private placement is slated to close in January next year, contingent upon approval by regulatory authorities in China.

“We appreciate our stockholders’ support for this financing with an investor that has expressed interest in NovaBay’s long-term success,” president & CEO Mark Sieczkarek said in prepared remarks. “We look forward to completing this financing and plan to use these funds to advance our Avenova growth strategy.”

The biopharmaceutical company is working to develop non-antibiotic products for the topical anti-infective market. NovaBay is developing its Avenova product for the removal of microorganisms and debris on and around the eyelid.

NBY shares closed yesterday at $3.40 apiece, up 6.3%.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Optical/Ophthalmic, Pharmaceuticals, Wall Street Beat Tagged With: novabay

IN CASE YOU MISSED IT

  • FDA approves Tandem Diabetes’ advanced hybrid closed-loop controller
  • Senate confirms Dr. Stephen Hahn to lead FDA
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
  • Medicina recalls IV Luer Slip syringes
  • Eitan Group signs service agreement with Integrated Medical Systems
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookDrug Delivery Business News
Follow us on Twitter@DrugDeliveryNow
Connect with us on LinkedInLinkedIn

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS